Descripcion
Indicaciones
Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).
Mecanismo de accion
IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]
Farmacología
12.1 Como funciona IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]
Dosis
2.1 3 PFIC BYLVAY 40 mcg/kg, , 1 3 , 40 mcg/kg , 120 mcg/kg, 6 mg BYLVAY 19.5 kg BYLVAY 19.5 kg
Precauciones
5.1 BYLVAY (DILI) PFIC ALGS , 6 DILI ,2 ALGS PFIC , 6 8 , , BYLVAY ,
Contraindicaciones
IBAT BYLVAY , [ Precauciones 5.1 ]
Interacciones farmacológicas
7.1 , BYLVAY 4 4 [ Dosificacion (2.3)] , BYLVAY
Reacciones adversas
[ Precauciones(5.1)] [ Precauciones(5.2)] [ Precauciones(5.3)] 6.1 , , PFIC 1 24 , BYLVAY 40 mcg/kg 120 mcg/kg [ (14.1)]


